PI-3065
-
PI-3065
structure -
-
CAS No:
955977-50-1
-
Formula:
C27H31FN6OS
-
Chemical Name:
PI-3065
-
Synonyms:
PI-3065;6-(4-CyclopropylMethyl-piperazin-1-ylMethyl)-2-(5-fluoro-1H-indol-4-yl)-4-Morpholin-4-yl-thieno[3,2-d]pyriMidine;PI-3065|PI3065;4-(6-((4-(cyclopropylmethyl)piperazin-1-yl)methyl)-2-(5-fluoro-1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl)morpholine;6-((4-(cyclopropylmethyl)piperazin-1-yl)methyl)-2-(5-fluoro-1H-indol-4-yl)-4-morpholinothieno[3,2-d]pyrimidine;6-(4-CyclopropylMethyl-piperazin-1-ylMethyl)-2-(5-fluoro-1H-indol-4-yl)-4-Morpholin-4-yl-thieno[3,2-d]pyriMidine PI-3065;PI-3065, >=98%;6-[[4-(Cyclopropylmethyl)-1-piperazinyl]methyl]-2-(5-fluoro-1H-indol-4-yl)-4-(4-morpholinyl)-thieno[3,2-d]pyrimidine
- Categories:
-
CAS No:
Computed Properties
Molecular Weight:506.6
XLogP3:3.7
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:6
Exact Mass:506.22640897
Monoisotopic Mass:506.22640897
Topological Polar Surface Area:88.8
Heavy Atom Count:36
Complexity:748
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of PI-3065
-
CN
3 YRS
Business licensedTrader Supplier of 1H,1H,2H,2H-PERFLUORODECYLTRIMETHOXYSILANE
Latest News on PI-3065
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
BOC-VAL-VAL-OH
69209-73-0
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Formula
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Formula
130349-01-8
-
Sildenafil Structure
139755-83-2
-
Dacomitinib Structure
1110813-31-4
-
What is Lenvatinib
417716-92-8
-
What is Osimertinib
1421373-65-0